LongeVC was created to support early-stage biotech and longevity-focused founders on their way to gain industrial momentum, raise capital, and grow to become the shapers of tomorrow's biotech industry.
We believe in the ecosystemic approach, supporting companies in complementary industrial sectors and building a broad biotech community of companies, which can exchange expertise and share successes.
We focus on teams which demonstrate:
We invest in companies that satisfy the following criteria:
Lean operational structure
The best talent in the field
Rapid execution up to seed-stage
First industrial validation or soft partnership commitments
in peer-reviewed journals
Seasoned business angel with exit track record in tech business and early investor in science-intensive ventures, such as Insilico Medicine and Basepaws
17 years of experience in traditional banking industry, 10 as a board member of largest privately owned bank in the Baltics. Ilya brings a large range of financial skills from AML/KYC to risk management and has over the years overseen a loan book of more than $1BN
Serial entrepreneur with 3 deep-tech ventures co-founded and $>20M raised in venture funding. Faculty to several universities in venture capital and intellectual property rights
CEO & Founder of Insilico Medicine, pioneer in AI-driven drug discovery and one of the most renowned longevity evangelists in the industry